ASFA
PFE icon

All Season Financial Advisors’s Pfizer PFE Stock Holding History

All Season Financial Advisors’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-7,004
Closed -$359K – 132
2022
Q4 		$359K Buy
+7,004
New +$336K 0.32% 72

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

All Season Financial Advisors's PFE Position: Q1 2023 in Review

All Season Financial Advisors sold out of Pfizer (PFE) in Q1 2023, closing a stake of 7,004 shares — an estimated $359K sold.

All Season Financial Advisors first reported a position in PFE in Q4 2022 and held it in 1 quarter. The position peaked at $359K in Q4 2022. 3,103 funds tracked by Wall St. Rank hold PFE as of Q1 2023.

  • All Season Financial Advisors reported no remaining Pfizer position as of Q1 2023 after selling out during the quarter.
  • All Season Financial Advisors sold 7,004 Pfizer shares in Q1 2023, an estimated $359K.
  • All Season Financial Advisors first reported a position in Pfizer in Q4 2022 and held it in 1 quarter.
  • All Season Financial Advisors's Pfizer position peaked at $359K in Q4 2022.
  • 3,103 funds tracked by Wall St. Rank held Pfizer as of Q1 2023.

Based on All Season Financial Advisors's 13F filing for Q1 2023, filed 17 Apr 2023.